IVERIC bio Revenue and Competitors
Estimated Revenue & Valuation
- IVERIC bio's estimated annual revenue is currently $19.1M per year.
- IVERIC bio's estimated revenue per employee is $192,576
- IVERIC bio's total funding is $35M.
- IVERIC bio's current valuation is $1.6B. (January 2022)
Employee Data
- IVERIC bio has 99 Employees.
- IVERIC bio grew their employee count by -49% last year.
IVERIC bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Chair, President, and CEO | Reveal Email/Phone |
2 | SVP, Chief Staff | Reveal Email/Phone |
3 | Chief Human Resources Officer | Reveal Email/Phone |
4 | CEO, Member the Board Directors | Reveal Email/Phone |
5 | VP Clinical Affairs | Reveal Email/Phone |
6 | SVP and Head Quality | Reveal Email/Phone |
7 | Sr. VP, Global Head Biometrics | Reveal Email/Phone |
8 | VP CMC | Reveal Email/Phone |
9 | VP Clinical Development | Reveal Email/Phone |
10 | VP Clinical Operations | Reveal Email/Phone |
IVERIC bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 3 | 0% | N/A | N/A |
#2 | N/A | 20 | 43% | N/A | N/A |
#3 | $6.7M | 33 | -6% | N/A | N/A |
#4 | $34.4M | 222 | -1% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $10M | N/A |
#6 | $2M | 13 | 0% | N/A | N/A |
#7 | $7.5M | 37 | 0% | $51.6M | N/A |
#8 | $0.3M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 21 | -16% | $3.3M | N/A |
#10 | $3.6M | 20 | 5% | N/A | N/A |
What Is IVERIC bio?
IVERIC bio is a gene therapy focused company developing innovative treatments for patients with orphan inherited retinal diseases with significant unmet medical needs. We have a diversified and scientifically compelling pipeline of product candidates. At IVERIC bio we understand the critical importance of vision in the quality of life of patients.
keywords:N/A
$35M
Total Funding
99
Number of Employees
$19.1M
Revenue (est)
-49%
Employee Growth %
$1.6B
Valuation
N/A
Accelerator
IVERIC bio News
IVERIC bio, Inc. (NASDAQ:ISEE Get Rating) has received a consensus recommendation of Buy from the eight research firms that are...
IVERIC bio also reported earnings of ($0.29) per share during the same quarter last year. The business is scheduled to issue its next earnings...
IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.1M | 99 | -16% | N/A |
#2 | $15.1M | 99 | -1% | N/A |
#3 | $24.8M | 99 | -56% | N/A |
#4 | $32.2M | 99 | -15% | N/A |
#5 | $14.6M | 99 | 13% | N/A |